Effect of protein kinase C inhibition on hypoxic pulmonary vasoconstriction

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 280, Issue 5 25-5, 2001, Pages

  Barman, Scott A ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Hypoxia; Thymeleatoxin

Indexed keywords

12 (2 CYANOETHYL) 6,7,12,13 TETRAHYDRO 13 METHYL 5 OXOINDOLO[2,3 A]PYRROLO[3,4 C]CARBAZOLE; CALPHOSTIN; NIFEDIPINE; PROTEIN KINASE C; PROTEIN KINASE C ACTIVATOR; STAUROSPORINE; THYMELEATOXIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY RESISTANCE; ARTICLE; BLOOD VESSEL COMPLIANCE; BLOOD VESSEL OCCLUSION; CONTROLLED STUDY; DRUG ACTIVITY; ENZYME INHIBITION; FEMALE; HYPOXIC LUNG VASOCONSTRICTION; ISOLATED LUNG; LUNG CAPILLARY PRESSURE; LUNG COMPLIANCE; LUNG VASCULAR RESISTANCE; MALE; NONHUMAN; PRIORITY JOURNAL;

EID: 0035036994     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.2001.280.5.l888     Document Type: Article

References (54)

1. Allison RC, Marble KT, Hernandez EM, Townsley MI, and Taylor AE. Attenuation of permeability lung injury after phorbol myristate acetate by verapamil and OKY-046. Am Rev Respir Dis 134: 93-100, 1986.
2. Archer SL, Yankovich RD, Chesler E, and Weir EK. Comparative effects of nisoldipine, nifedipine, and bepridil on experimental pulmonary hypertension. J Pharmacol Exp Ther 233: 12-17, 1985.
3. Audi SH, Dawson CA, and Linehan JH. A method for analysis of pulmonary arterial and venous occlusion data. J Appl Physiol 73: 1190-1195, 1992.
4. Audi SH, Dawson CA, Rickaby DA, and Linehan JH. Localization of the sites of pulmonary vasomotion by use of arterial and venous occlusion. J Appl Physiol 70: 2126-2136, 1991.
5. Barman SA. Effect of catecholamines on the pulmonary circulation at elevated vascular tone. J Appl Physiol 78: 1452-1458, 1995.
6. Barman SA. Pulmonary vasoreactivity to endothelin-1 at elevated vascular tone is modulated by potassium channels. J Appl Physiol 80: 91-98, 1996.
7. Barman SA. Pulmonary vasoreactivity to serotonin during hypoxia is modulated by ATP-sensitive potassium channels. J Appl Physiol 83: 569-574, 1997.
8. Barman SA. Potassium channels modulate canine pulmonary vasoreactivity to protein kinase C activation. Am J Physiol Lung Cell Mol Physiol 277: L558-L565, 1999.
9. Barman SA and Ikeda SR. Phorbol ester potentiation of canine pulmonary vasoreactivity to histamine. J Appl Physiol 79: 102-106, 1995.
10. Barman SA, Pauly JR, and Isales CM. Canine pulmonary vasoreactivity to serotonin: role of protein kinase C and tyrosine kinase. Am J Physiol Heart Circ Physiol 272: H740-H747, 1997.
11. 2+-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters. J Biol Chem 257: 7847-7851, 1982.
12. Consigny PM. Phorbol amplification of serotonin-induced arterial contractions is endothelium dependent. Am J Physiol Heart Circ Physiol 257: H1174-H1179, 1989.
13. Damron DS, Nadim HS, Hong SJ, Darvish A, and Murray PA. Intracellular translocation of PKC isoforms in canine pulmonary artery smooth muscle cells by ANG II. Am J Physiol Lung Cell Mol Physiol 274: L278-L288, 1998.
14. Dempsey EC, Frid MG, Aldashev AA, Das M, and Stenmark KR. Heterogeneity in the proliferative response of bovine pulmonary artery smooth muscle cells to mitogens and hypoxia: importance of protein kinase C. Can J Physiol Pharmacol 75: 936-944, 1997.
15. Drake RE, Gaar KA, and Taylor AE. Estimation of the filtration coefficient of pulmonary exchange vessels. Am J Physiol Heart Circ Physiol 234: H266-H274, 1978.
16. 2+ conductance in a vascular smooth muscle cell line. Circ Res 62: 1049-1054, 1988.
17. 2+ flux, protein kinase C activation, and smooth muscle contraction. J Pharmacol Exp Ther 235: 267-273, 1985.
18. Hakim TS. Identification of constriction in large versus small vessels using the arterial-venous and double occlusion techniques in isolated canine lungs. Respiration 54: 61-69, 1988.
19. Hakim TS, Dawson CA, and Linehan JH. Hemodynamic responses of dog lung lobe to lobar venous occlusion. J Appl Physiol 47: 145-152, 1979.
20. Haller H, Lindschau C, Quass P, Distler A, and Luft FC. Differentiation of vascular smooth muscle cells and the regulation of PKCα. Circ Res 76: 21-29, 1995.
21. Hillier SC, Graham JA, Hanger CH, Godbey PS, Glenny RW, and Wagner WW Jr. Hypoxic vasoconstriction in pulmonary arterioles and venules. J Appl Physiol 82: 1084-1090, 1997.
22. Hofman WF and Ehrhart IC. Pulmonary vascular reactivity and permeability to alveolar hypoxia in the dog. J Appl Physiol 69: 1828-1835, 1990.
23. Jin N, Packer CS, and Rhoades RA. Pulmonary arterial contraction: signal transduction. Am J Physiol Lung Cell Mol Physiol 263: L73-L78, 1992.
24. Johnson A. PMA-induced pulmonary edema: mechanisms of the vasoactive response. J Appl Physiol 65: 2302-2312, 1988.
25. Johnson KJ and Ward PA. Acute and progressive lung injury after contact with phorbol myristate acetate. Am J Pathol 107: 29-35, 1982.
26. 2+-independent isoforms of PKC differentially translocate in smooth muscle. Am J Physiol Cell Physiol 263: C714-C719, 1992.
27. Kobayashi E, Nakano H, Morimoto M, and Tamaoki T. Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun 159: 548-553, 1989.
28. Linehan JH and Dawson CA. A three-compartment model of the pulmonary vasculature: effects of vasoconstriction. J Appl Physiol 55: 923-928, 1983.
29. Linehan JH, Dawson CA, and Rickaby DA. Distribution of vascular resistance and compliance in a dog lung lobe. J Appl Physiol 53: 158-168, 1982.
30. Liou YM and Morgan KG. Redistribution of protein kinase C isoforms in association with vascular hypertrophy of rat aorta. Am J Physiol Cell Physiol 267: C980-C989, 1994.
31. Loyd JE, Newman JH, English D, Ogletree ML, Meyrick BO, and Brigham KL. Lung vascular effects of phorbol myristate acetate in awake sheep. J Appl Physiol 54: 267-276, 1983.
32. Maggiorini M, Melot C, Gilbert E, Vermeulen F, and Naeje R. Pulmonary vascular resistance in dogs and minipigs - effects of hypoxia and inhaled nitric oxide. Respir Physiol 111: 213-222, 1998.
33. 2+, AA metabolites, and vasodilators. J Appl Physiol 74: 1310-1319, 1993.
34. 3 formation in cultured airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 257: L209-L216, 1989.
35. Nagasaka Y, Bhattacharya J, Nanjo S, and Gropper MA. Micropuncture measurement of lung microvascular pressure profile during hypoxia in cats. Circ Res 54: 90-95, 1984.
36. Nishizuka Y. The role of protein kinase C in cell surface signal transduction and tumor production. Nature 308: 693-698, 1984.
37. Nishizuka Y. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 258: 607-614, 1992.
38. Ohanian V, Ohanian J, Shaw L, Scarth S, Parker PJ, and Heagerty AM. Identification of protein kinase C isoforms in rat mesenteric small arteries and their possible role in agonist-induced contraction. Circ Res 78: 806-812, 1996.
39. Orton EC, Raffestin B, and McMurtry IF. Protein kinase C influences rat pulmonary vascular reactivity. Am Rev Respir Dis 141: 654-658, 1990.
40. Parker JC, Kvietys PR, Ryan KP, and Taylor AE. Comparison of isogravimetric and venous occlusion capillary pressures in isolated dog lungs. J Appl Physiol 55: 964-968, 1983.
41. + channels in canine pulmonary artery. Circ Res 77: 131-139, 1995.
42. Post JM, Hume JR, Archer SL, and Weir EK. Direct role for potassium channel inhibition in hypoxic pulmonary vasoconstriction. Am J Physiol Cell Physiol 262: C882-C890, 1992.
43. Roivainen R and Messing RO. The phorbol derivatives thymeleatoxin and 12-deoxyphorbol-13-O-phenylacetate-10-acetate cause translocation and down-regulation of multiple protein kinase C isozymes. FEBS Lett 319: 31-34, 1993.
44. Shimamoto Y, Shimamoto H, Kwan C, and Daniel EE. Differential effects of putative protein kinase C inhibitors on contraction of rat aortic smooth muscle. Am J Physiol Heart Circ Physiol 264: H1300-H1306, 1993.
45. Shirai M, Sada K, and Ninomiya I. Effects of regional alveolar hypoxia and hypercapnia on small pulmonary vessels in cats. J Appl Physiol 61: 440-448, 1986.
46. 2+ flux in A7r5 vascular smooth muscle cells. Mol Pharmacol 32: 37-42, 1987.
47. Toga H, Okazaki H, Ishigaki M, Noguchi T, Huang J, Fukunaga T, Nagasaka Y, Takahashi K, and Ohya N. Effect of hypoxia on pulmonary blood flow-segmental vascular resistance relationship in perfused cat lungs. J Appl Physiol 84: 1003-1010, 1998.
48. Townsley MI, Korthuis RJ, Rippe B, Parker JC, and Taylor AE. Validation of vascular double occlusion method for Ppc,i in lung and skeletal muscle. J Appl Physiol 61: 127-132, 1986.
49. Von Euler US and Liljestrand G. Observations on the pulmonary arterial blood pressure in the cat. Acta Physiol Scand 12: 301-320, 1946.
50. Xu Y, Stenmark KR, Das M, Walchak SJ, Ruff LJ, and Dempsey EC. Pulmonary artery smooth muscle cells from chronically hypoxic neonatal calves retain fetal-like and acquire new growth properties. Am J Physiol Lung Cell Mol Physiol 273: L234-L245, 1997.
51. 2+ independent contractions of vascular smooth muscle. Biochem Cell Biol 74: 51-65, 1996.
52. 2+ channel ligand sensitive responses to the phorbol ester 12-O-tetradecanoylphorbol 13-acetate in vascular smooth muscle. Can J Physiol Pharmacol 64: 1489-1496, 1986.
53. Weissmann N, Voswinckel R, Hardebusch T, Rosseau S, Ghofrani HA, Schermuly R, Seeger W, and Grimminger F. Evidence for a role of protein kinase C in hypoxic pulmonary vasoconstriction. Am J Physiol Lung Cell Mol Physiol 276: L90-L95, 1999.
54. Welling KL, Sander M, Ravn JB, Larsen B, Abildgaard U, and Amtorp O. Effect of alveolar hypoxia on segmental pulmonary vascular resistance and lung fluid balance in dogs. Acta Physiol Scand 161: 177-186, 1997.